Resources from the same session
Welcome and Introductions
Presenter: Cristina Saura Manich
Session: Seagen - Case by Case: Strategic Sequencing Considerations in 3L HER2+ Metastatic Breast Cancer (MBC)
Resources:
Webcast
Decision-making in 3L Following T-DXd Progression (Case-based discussion)
Presenter: Joyce O'Shaughnessy
Session: Seagen - Case by Case: Strategic Sequencing Considerations in 3L HER2+ Metastatic Breast Cancer (MBC)
Resources:
Webcast
Decision-making in 3L Progression With CNS Involvement (Case-based discussion)
Presenter: Michelino De Laurentiis
Session: Seagen - Case by Case: Strategic Sequencing Considerations in 3L HER2+ Metastatic Breast Cancer (MBC)
Resources:
Webcast
Charting the Course: Navigating the Landscape From Real-world Evidence to Future Studies
Presenter: Joseph Gligorov
Session: Seagen - Case by Case: Strategic Sequencing Considerations in 3L HER2+ Metastatic Breast Cancer (MBC)
Resources:
Webcast
Q&A
Presenter: All Speakers
Session: Seagen - Case by Case: Strategic Sequencing Considerations in 3L HER2+ Metastatic Breast Cancer (MBC)
Resources:
Webcast
Closing Remarks
Presenter: Cristina Saura Manich
Session: Seagen - Case by Case: Strategic Sequencing Considerations in 3L HER2+ Metastatic Breast Cancer (MBC)
Resources:
Webcast